Evogene EVGN
NASDAQ EVGN
$0.56 +0.00 (+0.36%)
At close: Aug 21, 2026 · 4:00 PM EDT

Evogene (EVGN) Income towards Parent Company (2012 - 2026)

Evogene (EVGN) posted Income towards Parent Company of -$5.9 million for Q1 2026, down 10.57% sequentially from -$5.3 million in Q4 2025, and down 126.9% YoY from $21.8 million in Q1 2025.

Evogene (EVGN) Income towards Parent Company (2012 - 2026) Analysis & Trends

Evogene has reported Income towards Parent Company for 15 years, with the latest figure at -$5.9 million in Q1 2026.

  • Quarterly Income towards Parent Company fell 126.9% year-over-year to -$5.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.8 million (down 169.21% YoY) and the FY2025 annual result came in at -$8.5 million, up 48.53% from the prior year.
  • Income towards Parent Company retreated to -$5.9 million in Q1 2026 per EVGN's latest filing, from -$5.3 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at $8.8 million in Q2 2022 and troughed at -$8.3 million in Q1 2022.
  • A 5-year average of -$2.3 million and a median of -$4.0 million in 2023 frame the typical range for Income towards Parent Company.
  • The sharpest annual moves came in 2022 and 2025: Income towards Parent Company soared 242.05% in 2022, then slumped 1343.33% in 2025.
  • Over 5 years, Income towards Parent Company stood at -$3.0 million in 2022, then slumped by 120.18% to -$6.6 million in 2023, then jumped by 106.47% to $427000.0 in 2024, then plunged by 1343.33% to -$5.3 million in 2025, then fell by 10.57% to -$5.9 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$5.9 million, -$5.3 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Evogene 4.38 Mn 4.38 Mn 204,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.87 Mn
Dec 31, 2025 -5.31 Mn
Sep 30, 2025 3.87 Mn
Jun 30, 2025 -4.46 Mn
Mar 31, 2025 -2.59 Mn
Dec 31, 2024 427,000.00
Sep 30, 2024 -7.63 Mn
Jun 30, 2024 5.42 Mn
Mar 31, 2024 -3.86 Mn
Dec 31, 2023 -6.60 Mn
Sep 30, 2023 -3.98 Mn
Jun 30, 2023 7.02 Mn
Mar 31, 2023 -6.27 Mn
Dec 31, 2022 -3.00 Mn
Sep 30, 2022 -6.54 Mn
Jun 30, 2022 8.82 Mn
Mar 31, 2022 -8.28 Mn
Dec 31, 2021 -7.37 Mn
Sep 30, 2021 -7.61 Mn
Jun 30, 2021 -6.21 Mn